Vivostat’s Technology Turns Blood Into Surgical Glue
Vivostat is a Danish company that uses the patient’s blood to create a personalized surgical glue (fibrin sealant) that can be used for surgical procedures and the treatment of diabetic ulcers.
feature1
Chembio Diagnostics Tackles Infectious Diseases with Rapid-Diagnostic Platform
Chembio Diagnostics specializes in the development of advanced diagnostic tests for infectious diseases such as HIV and syphilis.
[OneMedForum] Clarient Grows Along with Cancer Testing Market
The Aliso Viejo, Calif.-based company achieved several major milestones in 2009.
[OneMedForum] BioSante Pharmaceuticals
The company’s main products are LibiGel, a testosterone gel for women, and Elestrin, which is approved to treat menopause-related hot flashes.
LifeTech Capital Recommends NovaBay Pharmaceuticals
NovaBay of Emeryville, Calif., develops antimicrobial products for a variety of infections, including conjunctivitis, MRSA, the skin disease impetigo, and urinary tract infections.
Echo Therapeutics Rated Strong Spec Buy by Life Tech Capital
The significant differences between Echo Therapeutics’ Symphony system and the competition is the needle-free transdermal biosensor, clinical trials in the hospital setting and biosensor life.
[OneMedForum] Biomoda’s Platform for Early Cancer Detection
Biomoda’s CyPath diagnostic assay is based on molecular marker technology originally developed at the Los Alamos National Laboratory.
Access Pharma’s Drug Delivery Technology Is a Stealth Asset
Access Pharma (OTC: ACCP.OB) provided an update today on the status of its cobalamin-based oral drug delivery product development programs.
Healthcare Conference Updates: AUXL, CTIC, CYTX, KERX
Below are some updates and developments from the past week.
[OneMedForum] Immunocellular Therapeutics
The Los Angeles-based company discussed its recent clinical trials, including results from a Phase I study of ICT-107 to treat a deadly form of brain cancer called glioblastoma.